Title: The Innovations of Stephen Kwaku Dordunoo
Introduction
Stephen Kwaku Dordunoo is an inventor based in Halethorpe, MD (US). He currently works at Anji Pharmaceuticals Inc. Although he has not yet been granted any patents, his contributions to the field of pharmaceuticals are noteworthy. Dordunoo collaborates with talented individuals such as Alain D Baron and Mark S Fineman.
Latest Patent Applications
Dordunoo's latest patent applications include significant advancements in medical treatments. One application is titled "Compositions and Methods for Treating Metabolic Disorders." This application provides compositions and methods aimed at improving the pharmacokinetics and reducing the risk of adverse events from biguanide compound administration. It includes delayed release formulations that feature a lag phase release.
Another application is "Methods and Compositions for Treating Cancer." This application discloses pharmaceutical compositions containing tetrathiomolybdate (TTM). It also includes formulations that combine TTM with other co-drugs, such as diethylcarbamazine (DEC) and astaxanthin (ATX). The formulations consist of a delayed release oral form that releases TTM in the gastrointestinal tract after passing through the stomach, as well as an enteric oral form that is not delayed release. The methods described aim to treat cancer, assist cancer patients as an adjuvant therapy, and address pulmonary arterial hypertension through the administration of these pharmaceutical compositions.
Conclusion
Stephen Kwaku Dordunoo is an innovative inventor whose work at Anji Pharmaceuticals Inc. focuses on developing advanced pharmaceutical treatments. His latest patent applications reflect his commitment to improving healthcare through innovative solutions.